4//SEC Filing
Salvadori Daniel Gesua Sive 4
Accession 0001415889-25-002584
CIK 0000001800other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 7:08 PM ET
Size
8.5 KB
Accession
0001415889-25-002584
Insider Transaction Report
Form 4
Salvadori Daniel Gesua Sive
Senior Vice President
Transactions
- Exercise/Conversion
Option (right to buy)
2025-01-30−23,771→ 0 totalExercise: $38.40From: 2019-02-19Exp: 2026-02-18→ Common Shares (23,771 underlying) - Sale
Common shares without par value
2025-01-30$128.50/sh−23,771$3,054,574→ 125,697 total - Exercise/Conversion
Common shares without par value
2025-01-30$38.40/sh+23,771$912,806→ 149,468 total
Footnotes (1)
- [F1]Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
Documents
Issuer
ABBOTT LABORATORIES
CIK 0000001800
Entity typeother
Related Parties
1- filerCIK 0001620564
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 7:08 PM ET
- Size
- 8.5 KB